MTN-037

A Phase I study that evaluated whether a microbicide gel called PC-1005 is safe for use in the rectum. The study, which included 12 HIV-negative cisgender and transgender men and women at two sites in the U.S., will help determine whether further testing on the safety and acceptability of PC-1005 as a potential rectal microbicide for preventing HIV and other sexually transmitted infections (STIs) can be conducted in a larger population. Results are anticipated by late 2019.

 

MTN-037 Backgrounder

19-June-2018

 

See Also

MTN-037 Study Protocol

 

MTN-037 Study Page


Source URL: https://mtnstopshiv.org/news/studies/mtn037